Ambry
New Products Posted to GenomeWeb: Ambry Genetics, Zymo Research
New products and services recently posted on GenomeWeb.
Labs, Doctors Still Grapple With Patient Recontact Despite Streamlined Variant Reclassification
Premium
Although leading labs have coalesced around the value of protocols for making sure updated variant calls get to patients, strategies still vary and practical challenges remain.
Ambry Genetics, Pacific Biosciences to Sequence up to 7K Human Genomes for Rare Disease Study
The firms were selected by the University of California, Irvine and the GREGoR Consortium to support a program to understand the genetic causes of rare diseases.
Cancer Sequencing Labs, Advocacy Groups Partner to Increase Genetic Testing Access
The newly launched INTERACT coalition said it will try to press medical and industry guidelines to keep pace with evidence surrounding inherited cancer risk.
Ambry Genetics, Tempus to Offer Paired Germline and Somatic Oncology Testing Services
Under the agreement, Ambry is performing germline sequencing and specialized variant interpretation for Tempus to support its Tempus xG and xG+ assays.